![β-D-Glucopyranosiduronic acid, 2-[[3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]amino]-4-(hydroxymethyl)phenyl, methyl ester, 2,3,4-triacetate](https://img.chemicalbook.com/CAS/20211123/GIF/894096-02-7.gif)
LN-366032
β-D-Glucopyranosiduronic acid, 2-[[3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]amino]-4-(hydroxymethyl)phenyl, methyl ester, 2,3,4-triacetate , 98% , 894096-02-7
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 869.2±65.0 °C(Predicted) |
| Density | 1.40±0.1 g/cm3(Predicted) |
| pka | 11.63±0.46(Predicted) |
| form | Solid |
| color | White to light yellow |
| InChIKey | COFWDBMZXNIYIR-SGMQXZHUNA-N |
| SMILES | C(C1C2=CC=CC=C2C2=CC=CC=C12)OC(=O)NCCC(=O)NC1C=C(CO)C=CC=1O[C@@H]1O[C@H](C(=O)OC)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C |&1:32,34,39,44,49,r| |
Description and Uses
Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319 |
| Precautionary statements | P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330 |